TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mortality at 28 days after post-extubation respiratory failure
Endpoint domain: Mortality/survival
Primary endpoint: Chronic Obstructive Pulmonary Disease and Asthma Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Dyspnea-12 Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completion of MSS training
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Desire as measured by Visual VITM Self-Reported Likert Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hamstring Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: COSI scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of serum biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of Extended Glasgow Outcome Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with positive head CT scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily weight gain during the first phase of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Daily weight gain during the transition phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Edema redevelopment during the transition phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Aminoglycoside dosing outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Patient-reported frequency of attempting sexual intercourse
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change in neurological trajectories
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in cognitive trajectories
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in functional trajectories
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pregnancy-Unique Quantification of Emesis (PUQE) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain interference change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total catecholamine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Overlapping Coefficient - POC %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asymmetry index - ASIM %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activation Index - ATTIV %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TORQUE %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMPACT %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels in new mothers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: COPD Exacerbation Number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of Life for the device
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mMRC dyspnea scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: peak germinal center B cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Thrombosis incidence
Endpoint domain: Mortality/survival
Primary endpoint: Rate of venous thromboembolism recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Collateral status improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Passive range of motion of the most affected upper limb joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freezing of Gait Questionnaire (FOGQ) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in circulating deoxyribonucleic acid (ctDNA) level related to progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients receiving supportive oncology care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Interference Scale of the Brief Pain Inventory
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ROM Elbow (Flexion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ROM Elbow (Extension)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ROM Forearm (Supination)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ROM Forearm (Pronation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Callback and Biopsy Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Successful initiation on ECMO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Verbal Behavior Milestones Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local control rate of cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occlusal stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occlusal analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90 day morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Eligible Youth-Parent Dyads Who Agree to Participate in the Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant Dyads Who Completed Follow-up Assessments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participating Parents' Satisfaction With the Intervention (Texting Arms Only)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diaphragmatic dysfunction by physiological parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of mean score of FACT-Lym quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with elevated Serum Fasting Insulin and Serum Fasting glucose scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in baseline Gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of PSVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: GLUT4 gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hematology Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder Rate (Reduction in Seizures)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Spare respiratory capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Maximal respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Basal respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Identification of pelvic lymph node metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Validated Investigator Global Assessment for Atopic Dermatitis score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasma concentration of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Radiologic Progression Free Survival (rPFS) for soft tissue lesions
Endpoint domain: Mortality/survival
Primary endpoint: Radiologic Progression Free Survival (rPFS) for bone lesions
Endpoint domain: Mortality/survival
Primary endpoint: Bone height changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mothers' use of non-pharmacological methods
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Residual β-Cell function (RBCF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: superior mesenteric artery resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: renal artery resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Safety of Ad-TD-nsIL12 intratumoral injection
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Score of DHEQ Section 2 - Total Score (Q1-34)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Variable footprint planting surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major respiratory complication in hospital
Endpoint domain: Adverse events/effects
Primary endpoint: Minor respiratory complication in hospital
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate for correctly interpreting a tactile numeric plot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to completion of a tactile board game
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Success rate to completion for a fake money counting task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-rating anxiety scale (SAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of balance confidence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pittsburgh Sleep Quality Index (PUKI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Aspartate transaminase concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alanine transaminase concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle tissue oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric Mid-Thigh Pull (IMTP)_relative peak force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wingate Anaerobic Test (WAnT)_relative peak power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LCBImm4 difference of DEB-treated LRPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean arterial pressure after intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of HCC detected at late stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Headache Impact Test 6
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: incidence of post spinal hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of hepatitis C virus
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and proportion of subjects with adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Abilhand Kids
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: GMFM 66
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IPFAM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fixation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of UI episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage reduction (%) in the number of UI episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Events- incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Post-intervention exercise attendance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of acute kidney graft rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of facilitation to Belatacept monotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in metabolic syndrome severity score (Z score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Haematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in RBC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of positional nystagmus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative pulmonary complication
Endpoint domain: Adverse events/effects
Primary endpoint: Vibrio cholerae infection incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Pain evaluation by VAS self-assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma S-adenosylmethionine (SAM) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma S-adenosylhomocysteine (SAH) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Solid-phase gastric emptying time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Score on Gastroparesis Cardinal Symptom Index (GCSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Left Ventricular Ejection Fraction (LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in patient-reported dyspnea
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intestinal health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical Benefit per RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum level of glutathione peroxidase 4 (GPX4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Cervical ROM --Universal Goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of blood pressure levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Technical success of VCBA transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MTD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Esophageal Temperature Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients benefiting from treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average weekly SBM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Weeks Retained in Substance Use Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean in kidney acetate uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean in kidney acetoacetate uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean in kidney acetoacetate metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean in kidney acetate metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 28 days ventilator-free day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Posture analysis score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of hospitalizations for heart failure at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: All cause death at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Muscle oxygenation (SmO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Physical Intimate Partner Violence (IPV) overtime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Verbal Intimate Partner Violence (IPV) overtime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Physical Child Maltreatment overtime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Verbal Child Maltreatment overtime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microglial activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients with a change in cardiac condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of change in cardiac arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of change in fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of change in hemodynamic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Binary change in pericarditis status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood biomarker level of neuron-specific enolase (NSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood biomarker level of protein S100
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood biomarker level of neurofilament light chain (NfL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in the International Restless Legs Severity (IRLS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality at 28 days post-randomization
Endpoint domain: Mortality/survival
Primary endpoint: Evolution of organ dysfunction (SOFA score difference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bag-mask ventilation skills immediately after training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of range of motion of the knee overground
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Composite Major Adverse Cardiac Event (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery of cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Center of pressure position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount and consistency of stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Depression-anxiety scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of CAR T cell infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cumulative incidence of COPD exacerbation
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative incidence of hospitalization for pneumonia
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Hypoxic Ischemic Encephalopathy
Endpoint domain: Mortality/survival
Primary endpoint: distribution of lower respiratory tract diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fetal membrane thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chromosomal abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of ProAgio combined with gemcitabine and nab paclitaxel
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of GourMed© meal
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients passively immunised with nirsevimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of targeted axillary lymph node dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in scores on the validated Sleep Quality Scale (SQS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in time asleep recorded by a wearable sleep tracker
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in sleep score given by wearable sleep tracker
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: mMRC dyspnea scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes